<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Brakke Consulting&#x306E;&#x30A6;&#x30A7;&#x30D6;&#x30B5;&#x30A4;&#x30C8;</provider_name><provider_url>https://brakkeconsulting.com/ja</provider_url><title>News from Brakke Consulting</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="uR9XHakeRC"&gt;&lt;a href="https://brakkeconsulting.com/ja/20054/"&gt;2004&#x5E74;7&#x6708;16&#x65E5;&#x306E;&#x52D5;&#x7269;&#x5065;&#x5EB7;&#x30CB;&#x30E5;&#x30FC;&#x30B9;&#x3068;&#x30CE;&#x30FC;&#x30C8;&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://brakkeconsulting.com/ja/20054/embed/#?secret=uR9XHakeRC" width="600" height="338" title="&#x201C;Animal Health News &amp; Notes for July 16, 2004&#x201D; &#x2014; Brakke Consulting Website" data-secret="uR9XHakeRC" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://brakkeconsulting.com/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;</html><description>printer friendly version ******************************************************************* &nbsp;Brakke Consulting&rsquo;s &nbsp;Animal Health News &amp; Notes for July 16, 2004 &nbsp;Copyright &copy; Brakke Consulting, Inc. ******************************************************************* IN THE NEWS: &nbsp; other news: Agenix Bioniche Del Monte Merial MorphoSys Novartis Novoplant Peptech Premium Standard Farms &nbsp; ****************************************************************** WONDERING WHAT YOUR CUSTOMERS ARE THINKING? &nbsp; Brakke Consulting maintains proprietary databases of well over 1,000 small animal veterinarians, as well as several hundred equine veterinarians, available for market research projects.&nbsp; Surveys can be web-based or conducted via fax with a turnaround time of less than a month.&nbsp; We also offer market surveying capabilities using your company&rsquo;s customer lists.&nbsp; &nbsp; If you&rsquo;re looking for information to help shape your marketing programs, or considering a new product launch, we can give you up-to-the-minute feedback from the people who will determine your success.&nbsp; &nbsp; For more information, please call 972-243-4033 or email Lynn Fondon at lfondon@brakkeconsulting.com. &nbsp; ****************************************************************** COMPANY NEWS RELEASES &nbsp; &gt;&nbsp; Merial announced its entry into the cattle implant market with Duralease (estradiol benzoate), a first-of-its-kind implant that uses liquid suspension technology.&nbsp; Duralease is the only implant to combine the benefits of a sustained-release estradiol benzoate implant with the consistency of patented Theraphase (microencapsulation) technology.&nbsp; The suspension implant uses a standard syringe to deliver a small 1-mL dose, which makes it less invasive and eliminates special equipment and pellets.View Full Post;</description></oembed>
